Sang Ho, MA is Vice President, at the Bilix which Biotech in south korea. He is expert member of MFDS (Ministry of Food & Drug Safety) & judge member of KDDF. (Korea Drug Development Fund) His current research area is acute & chronic inflammatory disease & drug delivery system. Pursuing this R&D agenda he has recently been working with global CRO & CMO. He wrote his Ph.D. on the specific chemistry for drug development at the Graduate Institute in south korea. Since 2006, he has been a senior researcher of JW Pharma & GC Pharma for more than 14 years. And he joined Bilix in 2019 and is currently the head of the research institute and Chief Development Officer.
